The table below is a selection guide to find the right diagnostic tool for the relevant cancer.

A more detailed selection guide can be found under Which Test for Whom?.

Explanations to the table:

• Symbols:
  • A green check indicates that the diagnostic can be used.
  • A red cross indicates that the diagnostic cannot be used.
  • Brackets around the green checks indicate that the test cannot be used without restriction.
    • At an early tumor stage the efficacy tests are only useful if a drug therapy is reasonable.
    • For the efficacy prediction the testable drugs are limited.
• Patient Sample:
  • A solid tumor is a tumor that arises in body tissue. For example breast, colon, ovary, lung or prostate cancer (to name a few).
  • Living tumor is either solid tumor tissue or malignant effusion, which is sent to TherapySelect directly after removal from the patient (via surgery, biopsy or puncture) and is being processed in a way that living tumor cells can be used for the test.
  • Tumor material FFPE (Formalin Fixed, Paraffin Embedded) is removed tumor tissue that is fixed in formalin and embedded in paraffin. Here no living tumor cells are present. It is also called archived tumor material. This is normally stored in pathology.
• Efficacy Prediction:
  • The targeted therapies do also include anti-hormone drugs.
  • The efficacy prediction can also include the prediction of resistance.
  • For targeted therapies and immunotherapies the CTR-Test^® is not yet validated.